Cedric Francois - 27 Aug 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Cedric Francois
Issuer symbol
APLS
Transactions as of
27 Aug 2025
Net transactions value
-$6,352,743
Form type
4
Filing time
29 Aug 2025, 16:19:34 UTC
Previous filing
18 Jul 2025
Next filing
15 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Francois Cedric Chief Executive Officer, Director C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM /s/ David Watson, attorney-in-fact for Cedric Francois 29 Aug 2025 0001658080

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $4,934,293 -175,037 -33% $28.19 357,909 27 Aug 2025 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2) F1, F2
transaction APLS Common Stock Sale $1,418,450 -49,963 -14% $28.39 307,946 28 Aug 2025 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2) F2, F3
holding APLS Common Stock 331,605 27 Aug 2025 Direct
holding APLS Common Stock 472,065 27 Aug 2025 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023) F4
holding APLS Common Stock 300,000 27 Aug 2025 Indirect Owner (The Francois Grossi Trust) F5
holding APLS Common Stock 234,411 27 Aug 2025 Indirect Owner (The Francois-DuBois Educational Trust) F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.78 - $28.49, inclusive. The reporting person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
F2 The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.14 - $28.68, inclusive.
F4 The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F5 The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F6 The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.